Abbisko Therapeutics, a Chinese biotech start-up that develops drugs for cancer treatment, announced on Friday that it has raised US$42 million in a new round of financing led by Chinese venture capital firm Qiming Venture Partners.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?